As was to be expected, mergers and acquisitions in the medtech sector slowed down quite a bit in the first half of 2020 as the COVID-19 pandemic boxed out many elective procedures and regular clinic visits. Less expected, however, was the industry’s meteoric recovery, which saw M&A activity rapidly bounce back to previous levels—and just […]

Athira Pharma announced its Phase 2 ACT-AD trial is fully enrolled and its Phase 2/3 LIFT-AD trial has reached more than half of its target number. Both studies are evaluating the safety and efficacy of ATH-1017 in people with mild to moderate Alzheimer’s disease. Eligible adults, ages 55 to 85, are still being recruited for the LIFT-AD […]

The test is an aid in differentiating sepsis from infection-negative systemic inflammation in hospitalised patients suspected of sepsis. Immunexpress has been a leader in host response sepsis diagnostics, and this second FDA clearance translates its biomarker technology to the sample-to-answer Biocartis Idylla near-patient testing platform. SeptiCyte RAPID contains all the reagents needed for quantification of […]